BMC Medical Co., Ltd. (SHE:301367)
China
· Delayed Price · Currency is CNY 67.26
+0.26 (0.39%)
At close: Apr 29, 2026
BMC Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2019 |
| Market Capitalization | 5,978 | 7,617 | 5,601 | 7,792 | 14,052 | - | Upgrade
|
| Market Cap Growth | -16.65% | 36.00% | -28.12% | -44.55% | - | - | Upgrade
|
| Enterprise Value | 3,513 | 5,152 | 3,021 | 5,363 | 13,467 | - | Upgrade
|
| Last Close Price | 67.26 | 85.71 | 62.71 | 85.50 | 152.72 | - | Upgrade
|
| PE Ratio | 31.15 | 33.76 | 36.05 | 26.21 | 36.95 | - | Upgrade
|
| Forward PE | 22.80 | 27.93 | 23.74 | 32.85 | 29.83 | - | Upgrade
|
| PS Ratio | 4.97 | 6.57 | 6.64 | 6.94 | 9.93 | - | Upgrade
|
| PB Ratio | 1.93 | 2.50 | 1.97 | 2.80 | 5.37 | - | Upgrade
|
| P/TBV Ratio | 1.96 | 2.54 | 1.98 | 2.81 | 5.40 | - | Upgrade
|
| P/FCF Ratio | 67.78 | 77.77 | 40.54 | 61.36 | 39.98 | - | Upgrade
|
| P/OCF Ratio | 48.38 | 58.52 | 36.35 | 51.57 | 37.45 | - | Upgrade
|
| PEG Ratio | - | 0.48 | 0.48 | 0.48 | - | - | Upgrade
|
| EV/Sales Ratio | 2.92 | 4.44 | 3.58 | 4.78 | 9.52 | - | Upgrade
|
| EV/EBITDA Ratio | 14.77 | 21.95 | 27.58 | 19.54 | 33.35 | - | Upgrade
|
| EV/EBIT Ratio | 16.21 | 23.07 | 31.15 | 20.27 | 33.82 | - | Upgrade
|
| EV/FCF Ratio | 39.83 | 52.60 | 21.87 | 42.23 | 38.32 | - | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.03 | 0.14 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.21 | 0.34 | 3.39 | 0.09 | 0.05 | 0.03 | Upgrade
|
| Debt / FCF Ratio | 0.56 | 0.86 | 2.92 | 0.21 | 0.06 | 0.04 | Upgrade
|
| Net Debt / Equity Ratio | -0.80 | -0.82 | -0.85 | -0.90 | -0.95 | -0.82 | Upgrade
|
| Net Debt / EBITDA Ratio | -10.88 | -10.66 | -21.98 | -9.10 | -6.18 | -2.61 | Upgrade
|
| Net Debt / FCF Ratio | -28.11 | -25.54 | -17.42 | -19.66 | -7.10 | -4.29 | Upgrade
|
| Asset Turnover | 0.36 | 0.34 | 0.27 | 0.38 | 0.80 | 1.22 | Upgrade
|
| Inventory Turnover | 5.28 | 5.10 | 4.08 | 3.86 | 5.17 | 4.59 | Upgrade
|
| Quick Ratio | 10.01 | 8.37 | 5.19 | 23.65 | 9.06 | 3.44 | Upgrade
|
| Current Ratio | 10.81 | 9.05 | 5.42 | 24.86 | 9.85 | 4.59 | Upgrade
|
| Return on Equity (ROE) | 6.61% | 7.86% | 5.64% | 11.10% | 24.52% | 33.66% | Upgrade
|
| Return on Assets (ROA) | 4.01% | 4.10% | 1.91% | 5.66% | 14.02% | 17.35% | Upgrade
|
| Return on Invested Capital (ROIC) | 32.57% | 40.66% | 24.22% | 115.02% | 334.52% | 218.07% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.00% | 7.30% | 3.40% | 9.40% | 15.10% | 30.40% | Upgrade
|
| Earnings Yield | 3.21% | 2.96% | 2.77% | 3.82% | 2.71% | - | Upgrade
|
| FCF Yield | 1.48% | 1.29% | 2.47% | 1.63% | 2.50% | - | Upgrade
|
| Dividend Yield | 0.98% | 0.77% | 0.64% | 1.17% | 0.94% | - | Upgrade
|
| Payout Ratio | 21.32% | 18.58% | 42.34% | 43.05% | - | 19.77% | Upgrade
|
| Buyback Yield / Dilution | 0.33% | 0.52% | 0.29% | -26.33% | -5.67% | 0.16% | Upgrade
|
| Total Shareholder Return | 1.28% | 1.29% | 0.93% | -25.16% | -4.73% | 0.16% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.